p21
waf1/cip1 , an important regulator of the cell cycle, binds to PCNA and acts as a mediator of the growth suppressing and apoptosis promoting functions of p53. We report a hitherto unobserved polymorphism in the carboxy terminal domain (codon 149) of p21 waf1/cip1 gene, the domain encoding the PCNA binding motif. The codon 149 polymorphism (GAT?GGT) was observed in 42 of 50 (84%) esophageal squamous cell carcinomas (ESCCs) and eight of 50 (16%) normal individuals. The resultant amino acid substitution from aspartate to glycine may have vital implication in PCNA mediated cell cycle regulation by p21 waf1/cip1 . The second polymorphism at codon 31, involving a C?A transversion at nucleotide 168 (AGC?AGA) changing the amino acid from serine to arginine, was observed in 2/50 (4%) ESCCs at a relatively lower frequency in the Indian population than that reported in the West. No signi®cant association was observed between p21 waf1/cip1 polymorphism at codon 149 and p21 waf1/cip1 protein expression in ESCC in this cohort of patients. Interestingly, the frequency of p21 waf1/cip1 variants (codon 149) in ESCCs (18 of 19 cases) with wild-type p53 was signi®cantly higher than in tumors with p53 mutations, suggesting that this polymorphism aects the p53 pathway and may play an important role in esophageal tumorigenesis. Analysis of p21 waf1/cip1 expression in relation to p53 gene and protein status revealed its induction by p53
Introduction
Esophageal cancer (EC) ranks among the ten most common cancers globally, with extremely poor prognosis owing to insidious symptomatology, late clinical presentation and rapid progression (Landis et al., 1999) . Despite recent advancements in surgical techniques and pre-operative management, the ®ve-year disease free survival as well as overall survival of EC patients remain poor. EC shows wide geographical variation in incidence across the world, with a strong correlation with exogenous risk factors, namely, alcohol consumption and tobacco smoking in Western countries, and a variety of dietary factors confounded by nutritional de®ciency in several regions of India and China (Yu et al., 1988; Munoz and Day, 1996; Gaur et al., 1997) . The etiology of Esophageal Squamous Cell Carcinoma (ESCC) is multifactorial, with synergistic eect of environmental and dietary factors. High consumption of sun dried and picked vegetables, red chillies and spices in the Indian population are implicated as major predisposing factors to esophageal tumorigenesis (Siddiqi et al., 1991) . In addition, bidi smoking, pan chewing and pan-tobacco chewing have also been identi®ed as important risk factors for esophageal cancer in India (Notani, 1988) . The Indian population, with poor nutritional status and high exposure to these dietary risk factors may therefore serve as an important in vivo model to investigate the alterations in oncogenes and tumor suppressor genes implicated in the pathogenesis of EC, which may ultimately lead to the identi®cation of novel predisposing factors or molecular markers for early diagnosis.
The human p21 waf1/cip1 localized to the chromosome 6p 21.2 is a cyclin-dependent kinase inhibitor (CDKI) upregulated by wild-type tumor suppressor protein p53, whose cellular level is elevated by genotoxic stress leading to either cell cycle arrest or cell death (El-Deiry et al., 1995; Gujuluva et al., 1994) . A unique ability to associate the proliferating cell nuclear antigen (PCNA), an auxiliary factor for DNA polymerase d and e, distinguishes it from other cyclin dependent kinase inhibitors (CDKIs). The p21 waf1/cip1 gene encodes a 21 kDa protein, with two protein binding domains, a N-terminal domain which binds and inhibits cyclinCdk complexes, and a short sequence near the Cterminus (between amino acid residues 144 ± 151) which binds to PCNA resulting in the inhibition of DNA replication (Xiong et al., 1993; Chen et al., 1995) . While its ability to inhibit cyclin/CDK complexes resulting in G 1 cell cycle arrest is well established, the genetic alterations of p21 waf1/cip1 motif responsible for its binding with PCNA and the consequences of p21 waf1/cip1 / PCNA interaction on cell cycle progression have not been completely understood. Expression of p21 waf1/cip1 inhibits PCNA-dependent DNA replication and mismatch repair in vitro and can suppress tumor growth suggesting its role as a tumor suppressor gene (FloresRozas et al., 1994; Li et al., 1994; Waga et al., 1994) . Alterations in p21 waf1/cip1 may therefore adversely aect the regulation of cellular proliferation and increase the susceptibility for cancer.
Mutations and deletions of p21 waf1/cip1 gene have been rare in human cancers, suggesting that p21 waf1/cip1 if involved in tumorigenesis, may be exerting itself mainly on the expression level rather than on the gene level (Shiohara et al., 1994; Heinzel et al., 1996) . However, p21 waf1/cip1 polymorphisms have been observed in various cancers. The polymorphic variants have been reported to occur more frequently in cancer patients than in healthy individuals suggesting a role in increased susceptibility for the development of some types of cancers (Mousses et al., 1995; Heinzel et al., 1996; Facher et al., 1997) . The goal of this study was to analyse the alterations in p21 waf1/cip1 gene and its expression as well as its relationship with p53 status in esophageal squamous cell carcinomas (ESCCs) in the Indian population, to determine their relevance in predicting predisposition to EC and potential as a diagnostic marker.
Results

Analysis of p21
waf1/cip1 gene polymorphism in ESCC patients and normal controls Genetic analysis of p21 waf1/cip1 was carried out in ESCCs (n=50), matched esophageal normal tissues and lymphocytes from ESCC patients as well as normal individuals (n=50). PCR ampli®cation of genomic DNA using exon 2 speci®c primers produced a 450 bp fragment which was sequenced. No somatic mutations were identi®ed. We hereby report a novel polymorphism at codon 149, one of the two conservative polymorphisms identi®ed at codon 31 and codon 149 in exon 2 of the p21 waf1/cip1 gene. Fortytwo of 50 (84%) ESCCs harbored an alteration at codon 149 involving a single nucleotide substitution, resulting in an A?G transition (GAT?GGT), thereby changing the predicted amino acid from aspartate to glycine (Figure 1 ). The detection of Asp/Gly substitution in ESCCs, paired normal esophageal tissues and lymphocytes in 42 of 50 cases suggests the occurrence of a novel polymorphism in the p21 waf1/cip1 gene ( Table  1 ). The occurrence of this polymorphism was also observed in 8/50 (16%) normal individuals in the Indian population, even though its frequency was signi®cantly higher in ESCC patients (p510
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, with an odds ratio of 27.56 and 95% con®dence interval=8.49, 94.98). The second alteration observed in 2/ 50 ESCCs was detected at codon 31, involving a C to A transversion at nucleotide 168(AGC?AGA) changing the amino acid from serine to arginine. This is a de®ned polymorphism observed in 5 ± 10% of the population (Koopmann et al., 1995) , residing in an area of 90% homology at the protein level with the murine homologue, which is proposed to encode a DNA-binding zinc ®nger domain (Huppi et al., 1994; El-Deiry et al., 1995) .
To understand the plausible role and biological signi®cance of p21 waf1/cip1 polymorphism in the process of esophageal tumorigenesis, we have sought to determine whether codon 149 variant is dierentially distributed in ESCCs where the p53 mutational spectrum had been determined by PCR ± SSCP and direct DNA sequencing of exons 5 ± 9 of p53 gene (Gaur et al., 1997; Ralhan et al., 1999) . Of the 34 ESCC cases analysed, 15 cases harbored a mutant p53 while the remaining 19 cases had wild-type p53. It is interesting to note that 18 of the 19 wild-type p53 cases showed p21 waf1/cip1 polymorphism at codon 149, reflecting a signi®cant association between codon 149 p21 waf1/ cip1 variant and wild-type p53 (p=0.009) ( Table 1) . Thirty-six of 44 cases overexpressing p53 protein harbored p21 waf1/cip1 codon 149 variant.
Immunochemical analysis of p21 waf1/cip1 protein expression in ESCCs
Immunohistochemical analysis of p21 waf1/cip1 protein expression was carried out in the same set of ESCCs, to investigate the clinical relevance of this polymorph- waf1/cip1 gene. Genomic DNA was isolated from frozen esophageal normal and tumor tissue specimen and lymphocytes by phenol-chloroform extraction. PCR amplification of genomic DNA was performed using speci®c p21 waf1/cip1 primers for exon 2: Primer 1 (exon 2 A.Fwd.) 5'-GCG CCA TGT CAG AAC CGG C-3'; Primer 2 (exon 2: A.Rev.) 5'-GAG AAT CCT GGT CCC TTA C-3'. 100 ml of PCR reaction mixture containing 10 ml of 106 PCR buer, 1.875 mM dNTP, 20 p mole of each primer, 200 ng template DNA and 1.5 units Taq polymerase. All reactions were performed in UV irradiated laminar¯ow and each batch of reaction included control in which no DNA template was added. The PCR conditions were: 948C for 4 min; 35 cycles of (1) denaturation at 948C for 30 s (2) annealing at 558C for 30 s and (3) Primer extension at 728C for 30 s followed by extension at 728C for 5 min. Agarose gel puri®ed PCR products were then used for direct DNA sequencing using automated DNA sequencer (Applied Biosystems 373 sequencer and AB1 Prism terminators). All the sequencing data were obtained by sequencing with both the forward and reverse primer Expression of p21 waf1/cip1 protein in esophageal squamous cell carcinomas and normal esophageal epithelium. Acetone ®xed frozen tissue sections were incubated with 0.3% H 2 O 2 in methanol for 20 min to quench endogenous peroxidase activity followed by 3% BSA blocking at room temperature for 20 min. The anti p21 waf1/cip1 monoclonal antibody (187, Santa Cruz Biotechnology, CA, USA) was used as primary antibody. Sections were incubated with primary antibody for 16 h at 48C. Color was developed using Vectastain ABC Elite Kit and di-aminobenzidine as chromogen as described previously (Gaur et al., 1997) . (+) Present (7) Absent. *Parts of the data have been published previously (Gaur et al., 1997) Novel waf1/cip1 by p53 independent pathway in a subset of tumors (Table 2) .
Discussion
The intriguing feature of our study was the alteration at codon 149 observed in the carboxy-terminal domain of the p21 waf1/cip1 gene which is involved in its binding to PCNA. The binding of p21 waf1/cip1 to PCNA has been shown to result in G 1 and G 2 cell cycle arrest in p53-de®cient cells (Cayrol et al., 1998) . The PCNA binding motif is located in the carboxy-terminal part of the p21 waf1/cip1 protein between residues 144 ± 151 (Chen et al., 1995; Goubin and Ducommun 1995; Nakanishi et al., 1995) . Alterations in this region, resulting in structural changes in the protein product, are therefore likely to lead to dierences in binding to PCNA, which is required for DNA replication and repair. Crystal structure studies of human PCNA complexed with a 22 residue PCNA binding peptide containing this motif have revealed that the p21 waf1/cip1 carboxyterminal domain interacts with the inter-domain connector loop of PCNA and is likely to prevent the interaction of PCNA with other components of polymerase assembly (Gulbis et al., 1996) . The PCNA binding site overlaps the nuclear localization signal (residues 140 ± 156) and the C-terminal cyclin binding site. Either the N-terminal CDK or the C-terminal PCNA binding region of p21 waf1/cip1 is sucient to inhibit DNA replication when expressed in cells (Chen et al., 1995; Luo et al., 1995) . The C-terminal domains of p21 waf1/cip1 might inhibit cell cycle progression independently of the N-terminal CDK inhibitory domain and thus contribute to the antiproliferative activity of p21 waf1/cip1 (Luo et al., 1995) . In a recent study p21 PCNA-variant was created by changing the amino acids at codons 147 (methionine), 149 (aspartic acid) and 150 (phenylalanine) to alanine, and the consequent structural changes were shown to abolish p21 waf1/cip1 /PCNA interaction resulting in both G 1 and G 2 arrest (Cayrol et al., 1998) . The ability of p21 waf1/cip1 to induce G 1 and G 2 /M cell cycle blocks in p53-de®cient DLD1 human colon cancer cells was due to p21 waf1/cip1 /PCNA interaction and not its association with CDKs. Thus, PCNA is the primary target of p21 waf1/cip1 mediated growth inhibition in DLD1 colon cancer cells and alterations in p21 waf1/cip1 C-terminal domain, especially at codons 147 ± 151 can aect the cell cycle regulation by p21 waf1/cip1 (Cayrol et al., 1998) . The A?G transition (GAT?GGT) at codon 149, manifested as a substitution of aspartate by glycine observed in the present study, will change the net charge of this domain, which may alter the molecular conformation and thereby inhibit the p21 waf1/cip1 /PCNA interaction. Therefore, we propose that the novel p21 waf1/cip1 polymorphism at codon 149 may in¯uence the antiproliferative activity of p21 waf1/ cip1 and account for increased susceptibility for development of cancer in individuals harboring this polymorphic variant. The data obtained in the parallel study in our laboratory exhibiting Asp/Gly polymorphism at codon 149 in betel and tobacco related oral squamous cell carcinomas in the Indian population may be of immense relevance in context to the current observation (unpublished observations). Taken together these data suggest that p21 waf1/cip1 polymorphism may play a role in increased susceptibility for the development of some types of cancer. The putative role of p21 waf1/cip1 polymorphism in esophageal tumorigenesis is further supported by the observation that 18 of 19 cases of the ESCCs having wild-type p53 showed p21 waf1/cip1 polymorphism at codon 149 suggesting that this polymorphism in¯uences p21
waf1/cip1 function in such a way as to obviate the requirement for p53 mutations to deregulate the cell cycle. A similar inference has been drawn for p21 waf1/cip1 polymorphism at codon 31, and a C?T transition 20 nucleotides downstream of the stop codon in the 3' UTR from the observation that these polymorphic variants were under-represented in breast cancer and sarcoma patients, whose tumors possessed somatic p53 mutations compared to those without mutations, suggesting that they in¯uence p21 waf1/cip1 mediated cell cycle regulation in a p53 independent manner (Mousses et al., 1995) .
Analysis of p21 waf1/cip1 protein expression in relation to p53 gene status did not show any signi®cant association with p53 mutations. The loss of expression of p21 by p53 independent pathway(s) in a subset of tumors. The lack of an absolute correlation between p21 waf1/cip1 expression and status of p53 gene or p53 protein in ESCCs is consistent with previous reports suggesting p53 independent pathways for the regulation of p21 waf1/ cip1 expression in human tumors (El-Deiry et al., 1995; Vidal et al., 1995; Barbareschi et al., 1996; Doglioni et al., 1996; Elbendary et al., 1996; Marchetti et al., 1996a,b; Agarwal et al., 1998) . In a recent study on evaluation of the signi®cance of molecular biological factors and clinicopathological parameters in relation to prognosis and recurrence in ESCCs in a multivariate analysis, Shimada et al. (1999) reported p21 waf1/cip1 and VEGF to be the key genes of esophageal cancer.
Summing up, to our knowledge this is the ®rst report on the novel polymorphism at codon 149, low frequency of polymorphism at codon 31, lack of somatic mutations in p21 waf1/cip1 gene and induction of p21 waf1/cip1 by p53 dependent and independent pathways in esophageal cancer in the Indian population. Alteration at codon 149 may be of potential clinical relevance since it may alter p21 waf1/cip1 /PCNA interacNovel polymorphism in p21 waf1/cip1 gene R Bahl et al tion, required for inhibition of DNA replication and subsequent activation of mismatch repair.
Materials and methods
Patients and controls
Fifty esophageal cancer cases enrolled in the Surgical Oncology Unit, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, India and 50 age and gender matched healthy controls were inducted into the study with prior consent. The patients and controls were interviewed to elicit information on their habit pattern. A structured questionnaire was used to collect information on various demographic, socio-economic, occupational, nutritional and life style variables including the consumption of red chillies, spices, polyunsaturated fats (oil), hot tea, alcohol and tobacco (chewing and/or smoking). These parameters were taken into consideration to select the patients and healthy controls with overlapping habitual patterns to minimize the contribution of these exogenous risk factors as far as possible. , monoclonal (187), Santa Cruz Biotechnology, Santa Cruz, CA, USA) or anti-p53 antibody (mAb, DO-1, Oncogene Science, Uniondale, NY, USA) for 16 h at 48C and washed with PBS. The primary antibody was detected using biotinylated secondary antibody and avidin-biotin complex by ABC method as described previously (Gaur et al., 1997) using Vectastain Elite kit and diaminobenzidine as chromogen. Incubations were performed at room temperature in a moist chamber. Slides were washed several times with PBS after each step. In negative controls, the primary antibody was replaced by PBS or non-immune mouse IgG of the same isotype to ensure speci®city. Human oral squamous cell carcinoma tissue sections known to overexpress p21 waf1/cip1 protein were used as the positive control in each batch of sections analysed (data not shown).
Positive criterion for immunohistochemical staining
The intensity of immunohistochemical staining was evaluated in ®ve areas of the slide sections for correlation and con®rmation of the tissue analysis. For p21 waf1/cip1 and p53 protein expression, speci®c staining in the nuclei was de®ned as positive staining (Bukholm et al., 1997; Gaur et al., 1997) . The results were evaluated semiquantitatively and graded on a 4-point-scale on the basis of percentage ± positive stained cells; (7)=immunostained positive cells not detected; (+1)= 510%; (+2)=10 ± 20%; (+3)=20 ± 40%; (+4)=440%. The intensity of staining was graded on the basis of color as intense (I), moderate (Mod), mild (m) and poor (P). The pattern of expression was described as focal (F), where wide clusters of positive cells were seen in some areas of the epithelium; diused (D), in which positive cells were found throughout most areas of the lesions; and scattered (S), in which only few isolated positive cells were identi®ed in some regions of the epithelium. The sections were counter-stained with methyl green. The immunostained slides were graded on the above mentioned 4-point-scale by four of us, independently (R Bahl, S Arora, M Mathur, (Professor of Pathology) and R Ralhan). More than 10% positive staining in the nuclei was de®ned as the cut o point chosen for both p21 waf1/ cip1 and p53 protein expression. Less than 10% positive nuclear staining (+1) was de®ned as the basal level of protein expression. The sections which did not show any detectable immunostaining were taken as negative.
DNA extraction
Genomic DNA was extracted from peripheral blood mononuclear cells, esophageal tumor and normal tissues by proteinase K digestion and phenol chloroform extraction as described previously (Sambrook et al., 1989) .
p21
waf1/cip1 gene ampli®cation by polymerase chain reaction (PCR)
The second and third exons of the p21 waf1/cip1 gene, previously shown to have a high incidence of mutations, were ampli®ed by polymerase chain reaction. The following primer sequences were synthesized (Rama Biotechnology Inc., New Delhi, India). The PCR reaction mixture consisted of 10 ml of 106 PCR buer, 20 p moles of each primer, 1.875 mM deoxynucleotide triphosphates, 1.5 units of Taq DNA polymerase (Perkin Elmer) and 200 ng genomic DNA in a ®nal volume of 100 ml. The PCR conditions were: denaturation at 948C for 4 min and 35 cycles of (1) denaturation of 948C for 30 sec, (2) annealing at 558C for 30 sec and (3) primer extension at 728C for 30 sec followed by autoextension 728C for 5 min. After PCR ampli®cation, the products were checked on 2% agarose gels by electrophoresis using the appropriate DNA molecular weight marker (1 kb DNA ladder from Gibco BRL).
Novel polymorphism in p21 waf1/cip1 gene R Bahl et al
DNA sequence analysis
The PCR products were puri®ed using low melting agarose gels by electrophoresis. The puri®ed products were used for direct DNA sequencing using automated DNA sequencer (Applied Biosystems 373 sequencer and ABI Prism terminators). Dierent types of controls were used in order to verify that the mutated alleles identi®ed are not artifacts of the sequencing assay. All the sequencing data were obtained by sequencing with both the forward and reverse primers. The sequencing data obtained were con®rmed twice by performing a complete repeat of the experimental procedure: ampli®cation of stock genomic DNA, PCR ampli®cation, fragment puri®cation and sequencing of both the DNA strands.
Statistical Analysis
The correlation between p21 waf1/cip1 or p53 protein expression and clinicopathological parameters of esophageal cancer patients was statistically evaluated using Chi-square test or Fischers exact test.
